Oncotarget New Insights into p53: A Powerful Gene’s Role in Cancer Therapy studies that employ TP53-wild type cancer cells and their isogenic derivatives may systematically fail to... read more April 22, 2025
Oncotarget Targeting SETDB1: A New Strategy for Treating Osteosarcoma Osteosarcoma is characterized by a complex genetic profile that leads to significant genetic instability, which... read more April 9, 2025
Oncotarget When the Cure Becomes the Cause: A Rare Case of Cancer from Donor Cells Donor cell-derived hematologic neoplasms are extremely rare complications that arise after hematopoietic stem cell transplantation."... read more March 26, 2025
Oncotarget A Rare Genetic Shift That Helped Lung Cancer Evade Treatment This case adds to the literature on bypass signaling as a mechanism of resistance to... read more March 12, 2025
Oncotarget How a Simple Blood Test Could Predict Colorectal Cancer Surgery Success The concentration of cell-free DNA (cfDNA) before and after surgery may be related to the... read more February 26, 2025
Oncotarget A New Approach for Cancer Treatment: The Surprising Relationship Between KLRG1 and PD-1 The anti-correlation of PD-1 and KLRG1 expression in human tumor infiltrating CD8 T cells suggests... read more January 28, 2025
Oncotarget A New Path to Tumor Suppression: The Promise of PG3 Restoration of the p53 pathway has been a long-term goal in the field of cancer... read more December 18, 2024
Oncotarget Small Cell Lung Cancer: Advancing Precision Medicine with Biomarker Research Precision medicine is an innovative approach to disease prevention and treatment that considers differences in... read more December 4, 2024
Oncotarget Cancer Dormancy and Tumor Recurrence: New Insights for Breast Cancer Cancer dormancy, followed by recurrence remains a poorly understood phenomenon in both cancer biology and... read more November 13, 2024
Oncotarget Next-Generation Antibodies for Cancer Therapy This study focuses on developing a new generation of antibodies that can get inside cancer... read more October 24, 2024